Current Edition

How Integrated Technology Benefits Patients and Investigators in Diabetes Clinical Trials

Doctors are warning of the ‘absolute pandemic’ of diabetes. In
the US alone, 100 million are diagnosed with diabetes, with many
millions more undiagnosed or unaware of their condition. It is not
surprising that pharmaceutical companies are heavily investing in
this area. Researchers are, therefore, adopting technology to elevate
their clinical trials for better data, reduced burden on patients, and
increased patient safety. In this article, Jill V. Platko at CRF Health
explores how connected technology and electronic solutions can be
integrated specifically into diabetes clinical trials to meet the needs
of clinicians and patients.